ArticleClinics (Sao Paulo, Brazil)2026
The impact of intraoperative diagnosis of spontaneous bacterial peritonitis or bacterascites in liver transplantation.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBacterial infections can negatively impact post-liver transplant morbidity and mortality, and the impact of incipient spontaneous bacterial peritonitis or bacterascites from intraoperative ascitic fluid is unknown. The present study's objectives were to analyse the risk factors for post-liver transplant infection and survival within 30-days after transplant.
methodsThis is a single-center retrospective cohort study of liver transplant patients from 2010‒2017, whose ascitic fluid collected during transplant was sent for analysis. Survival analysis using the Kaplan-Meier method and Cox regression in the multivariate analysis was used to determine risk factors for post-transplant infection and survival.
resultsOf 297 patients, 22 had intraoperative SBP, 40 had bacterascites, and 235 had a normal ascitic fluid. 67% were male, median age 53-years, and median MELD score of 24. In multivariate analysis, there was no association between the presence of SBP or the presence of bacterascites and the occurrence of infection or death, and although it was not clinically significant, there was a trend towards worse survival in the bacterascites group. Patients undergoing post-transplant reoperation (OR = 2.28, 95% CI 1.12-4.60, p = 0.022), post-transplant MDR colonization (OR = 4.39, 95% CI 2.61-7.39, p < 0.001), and post-transplant dialysis (OR = 2.20, 95% CI 1.31-3.69, p = 0.003) had a higher rate of infection in the first 30-days after transplantation; pre-transplant MDR colonization, early graft dysfunction and low body mass index were independent predictors of worse survival.
conclusionsIntraoperative SBP and bacterascites that received targeted treatment did not impact infections nor survival rates up to 30-days after liver transplant, while most episodes were treated. In this population of severe patients with ascites, patients undergoing reoperation, post-transplant MDR colonization and post-transplant dialysis were at higher risk of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.